Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | TACR1 | P25103 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | CACNB1 | Q02641 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28656724 | 0.81 | SLC6A9 (0.45) | SLC6A9HSD17B10S1PR1TACR1ALDH1A1 | |
| SCHEMBL22215016 | 0.81 | SLC6A9 (0.45) | SLC6A9HSD17B10S1PR1TACR1ALDH1A1 | |
| SCHEMBL20281030 | 0.81 | SLC18A3 (0.45) | SLC6A9HSD17B10S1PR1ALDH1A1KDM4E | |
| SCHEMBL20822500 | 0.81 | SLC6A9 (0.45) | SLC6A9HSD17B10S1PR1TACR1ALDH1A1 | |
| SCHEMBL1270438 | 0.80 | SLC6A9 (0.47) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 | |
| SCHEMBL14516299 | 0.80 | SLC6A9 (0.47) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 | |
| SCHEMBL12156548 | 0.79 | SLC6A9 (0.44) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 | |
| SCHEMBL408919 | 0.79 | SLC6A9 (0.44) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 | |
| SCHEMBL7593926 | 0.79 | SLC6A9 (0.44) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 | |
| SCHEMBL12156561 | 0.79 | SLC6A9 (0.44) | SLC6A9HSD17B10S1PR1SIGMAR1TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697034-B2 | Hyperpolarized 89-yttrium and methods relating thereto | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-04-15 | — | — | US | claimed |
| US-20100092396-A1 | HYPERPOLARIZED 89-YTTRIUM AND METHODS RELATING THERETO | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-04-15 | — | — | US | claimed |
| CN-110286168-B | Method for determining polyamino polycarboxyl compound in developer | 浙江普利药业有限公司 | 2023-03-03 | — | — | CN | disclosed |
| US-8697034-B2 | Hyperpolarized 89-yttrium and methods relating thereto | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2014-04-15 | — | — | US | disclosed |
| US-20100092396-A1 | HYPERPOLARIZED 89-YTTRIUM AND METHODS RELATING THERETO | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2010-04-15 | — | — | US | disclosed |
| EP-1890604-A1 | X-RAY ARRANGEMENT FOR THE IMAGE REPRESENTATION OF AN EXAMINATION OBJECT AND USE OF THE X-RAY ARRANGEMENT | Bayer Schering Pharma AG (DE) | 2008-02-27 | — | — | EP | disclosed |
| US-20070025514-A1 | X-ray arrangement for graphic display of an object under examination and use of the x-ray arrangement | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2007-02-01 | — | — | US | disclosed |
| WO-2006131175-A1 | X-RAY ARRANGEMENT FOR THE IMAGE REPRESENTATION OF AN EXAMINATION OBJECT AND USE OF THE X-RAY ARRANGEMENT | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2006-12-14 | — | — | WO | disclosed |
| CN-1208338-C | Contrast enhancement agent of magnetic resonance imaging radiography for metal fullerene as well as its preparing method and usage | ZHAO YULIANG (CN) | 2005-06-29 | — | — | CN | disclosed |
| EP-0527131-A1 | CHELANTS | NYCOMED SALUTAR, INC. (US) | 1993-02-17 | — | — | EP | disclosed |
| WO-1991010645-A2 | CHELANTS | COCKBAIN, JULIAN, RODERICK, MICHAELSON (GB) | 1991-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100092396-A1 | HYPERPOLARIZED 89-YTTRIUM AND METHODS RELATING THERETO | TSPO, IPO11, SLC30A5 | SLC6A9 312/4885HSD17B10 3624/4885S1PR1 768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.